Skip to content

Observation on the clinical efficacy of the method of supporting the body and yang for lung cancer

Study on the Clinical Efficacy and Mechanism of Fuzheng Fuyang Method in Lung Cancer from the Perspective of Immune Editing

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001257
Enrollment
Unknown
Registered
2025-06-23
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Test group:Conventional chemotherapy combined with traditional Chinese medicine decoctions

Sponsors

Chongqing Medical University Affiliated Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Case selection criteria (1) Diagnostic criteria 1) Diagnostic criteria of Western medicine According to the 2018 edition of the Diagnosis and Treatment Guidelines for Primary Lung Cancer the diagnostic criteria for advanced non-small cell lung cancer are pathology Diagnosed as non-small cell lung cancer (mainly including adenocarcinoma squamous cell carcinoma etc.) staged diagnosis in accordance with the International Union Against Cancer The 8th edition of lung cancer staging (Appendix 1) released by UICC in 2017 includes stages IIIB-IV. 2) Diagnostic criteria of traditional Chinese medicine According to the 2017 version of the traditional Chinese medicine diagnosis and treatment plan for lung cancer the main manifestations of lung spleen qi deficiency combined with yang deficiency syndrome are: Exhausted and weak persistent coughing with thin phlegm chest tightness and shortness of breath bloating and drowsiness swollen and loose stools pale tongue with thin coating and teeth on the edges Traces with deep and fine veins. (2) Inclusion criteria 1) Patients with advanced non-small cell lung cancer undergoing chemotherapy who meet the diagnostic criteria of both traditional Chinese and Western medicine mentioned above; 2) Age between 18 and 75 years old gender is not restricted; 3) KPS score greater than 60 points expected survival period of more than six months; 4) Be conscious and fully understand the survey questionnaire; 5) No severe impairment in heart liver or kidney function; 6) Agree to receive treatment with traditional Chinese medicine decoction; 7) Voluntarily sign an informed consent form be able to persist in receiving treatment and complete the course of treatment according to regulations.

Exclusion criteria

Exclusion criteria: exclusion criteria 1) Secondary lung cancer or concomitant with other cancers; 2) Specialized treatment is required for severe systemic complications; 3) Currently using other treatments (drug or non drug interventions) to enhance immune function; 4) There are patients who are allergic to traditional Chinese medicine Fuzheng Fuyang Tang. 5) Poor compliance.

Design outcomes

Primary

MeasureTime frame
The levels of inflammatory factor indicators such as lymphocyte subsets, CCL2, CCR4, etc.;

Secondary

MeasureTime frame
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire;Traditional Chinese Medicine Syndrome Score;

Countries

China

Contacts

Public ContactZhang Yudi

Chongqing Medical University Affiliated Rehabilitation Hospital

perfect0316@163.com15123312298

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026